Shelley A. Gestl

851 total citations
15 papers, 670 citations indexed

About

Shelley A. Gestl is a scholar working on Molecular Biology, Social Psychology and Oncology. According to data from OpenAlex, Shelley A. Gestl has authored 15 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Social Psychology and 5 papers in Oncology. Recurrent topics in Shelley A. Gestl's work include Neuroendocrine regulation and behavior (5 papers), Cancer Cells and Metastasis (4 papers) and Neonatal and fetal brain pathology (3 papers). Shelley A. Gestl is often cited by papers focused on Neuroendocrine regulation and behavior (5 papers), Cancer Cells and Metastasis (4 papers) and Neonatal and fetal brain pathology (3 papers). Shelley A. Gestl collaborates with scholars based in United States, France and Canada. Shelley A. Gestl's co-authors include Edward J. Gunther, Allison S. Cleary, Joan Y. Summy‐Long, Massako Kadekaro, Mary Lee Terrell, Judith Weisz, Elizabeth E. Frauenhoffer, Debra A. Shearer, Hanwu Liu and Mitchell D. Green and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Molecular and Cellular Biology.

In The Last Decade

Shelley A. Gestl

15 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shelley A. Gestl United States 10 306 224 207 86 79 15 670
Anne Marie Martin United States 11 293 1.0× 386 1.7× 110 0.5× 94 1.1× 74 0.9× 18 847
Rajaâ El Meskini United States 18 437 1.4× 219 1.0× 148 0.7× 41 0.5× 29 0.4× 29 938
Lesley Castillo Australia 14 402 1.3× 208 0.9× 242 1.2× 25 0.3× 16 0.2× 18 948
Eva Sedlákova Czechia 12 218 0.7× 114 0.5× 77 0.4× 35 0.4× 31 0.4× 32 467
Youji Feng China 12 350 1.1× 187 0.8× 129 0.6× 80 0.9× 22 0.3× 33 582
Xianlong Gao United States 18 731 2.4× 156 0.7× 87 0.4× 43 0.5× 13 0.2× 53 1.0k
Steven Tucker United Kingdom 14 306 1.0× 141 0.6× 74 0.4× 50 0.6× 43 0.5× 49 725
Mitsuo Oshimura Japan 14 664 2.2× 175 0.8× 104 0.5× 286 3.3× 25 0.3× 20 1.0k
Y. A. Luqmani United Kingdom 13 467 1.5× 183 0.8× 50 0.2× 122 1.4× 50 0.6× 17 703
Zoltán Rékási United States 19 370 1.2× 290 1.3× 150 0.7× 189 2.2× 9 0.1× 38 1.2k

Countries citing papers authored by Shelley A. Gestl

Since Specialization
Citations

This map shows the geographic impact of Shelley A. Gestl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley A. Gestl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley A. Gestl more than expected).

Fields of papers citing papers by Shelley A. Gestl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelley A. Gestl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley A. Gestl. The network helps show where Shelley A. Gestl may publish in the future.

Co-authorship network of co-authors of Shelley A. Gestl

This figure shows the co-authorship network connecting the top 25 collaborators of Shelley A. Gestl. A scholar is included among the top collaborators of Shelley A. Gestl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelley A. Gestl. Shelley A. Gestl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Shuo, Shelley A. Gestl, & Edward J. Gunther. (2019). A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection. Cancer Prevention Research. 13(2). 173–184. 3 indexed citations
2.
Gestl, Shelley A., et al.. (2016). Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias. Carcinogenesis. 37(8). 810–816. 5 indexed citations
3.
Cleary, Allison S., et al.. (2014). Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 508(7494). 113–117. 351 indexed citations
4.
Plichta, Kristin A., et al.. (2012). Basal but not Luminal Mammary Epithelial Cells Require PI3K/mTOR Signaling for Ras-Driven Overgrowth. Cancer Research. 72(22). 5856–5866. 5 indexed citations
5.
Debies, Michael T., Shelley A. Gestl, Oliver R. Mikse, et al.. (2008). Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss. Journal of Clinical Investigation. 118(1). 51–63. 50 indexed citations
6.
Gestl, Shelley A., et al.. (2006). Dormant Wnt-Initiated Mammary Cancer Can Participate in Reconstituting Functional Mammary Glands. Molecular and Cellular Biology. 27(1). 195–207. 9 indexed citations
7.
Slusher, Leslie B., John T. Beneski, Shelley A. Gestl, et al.. (2003). Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis.. PubMed. 63(12). 3092–100. 47 indexed citations
8.
Gestl, Shelley A., Mitchell D. Green, Debra A. Shearer, et al.. (2002). Expression of UGT2B7, a UDP-Glucuronosyltransferase Implicated in the Metabolism of 4-Hydroxyestrone and All-Trans Retinoic Acid, in Normal Human Breast Parenchyma and in Invasive and in Situ Breast Cancers. American Journal Of Pathology. 160(4). 1467–1479. 48 indexed citations
9.
Summy‐Long, Joan Y., et al.. (2002). Nitric oxide, interleukin and prostaglandin interactions affecting the magnocellular system. Brain Research. 940(1-2). 10–20. 14 indexed citations
10.
Weisz, Judith, Shelley A. Gestl, Gary A. Clawson, et al.. (2000). Nuclear Localization of Catechol-O-Methyltransferase in Neoplastic and Nonneoplastic Mammary Epithelial Cells. American Journal Of Pathology. 156(6). 1841–1848. 23 indexed citations
11.
Summy‐Long, Joan Y., Shelley A. Gestl, Ellen Koehler-Stec, et al.. (1998). Effects of Central Injection of Kyotorphin and l-Arginine on Oxytocin and Vasopressin Release and Blood Pressure in Conscious Rats. Brain Research Bulletin. 45(4). 395–403. 11 indexed citations
12.
Kadekaro, Massako, et al.. (1998). Effects ofl-NAME on cerebral metabolic, vasopressin, oxytocin, and blood pressure responses in hemorrhaged rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 274(4). R1070–R1077. 36 indexed citations
13.
Summy‐Long, Joan Y., et al.. (1997). Osmoregulation of the magnocellular neuroendocrine system during lactation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 272(1). R275–R288. 8 indexed citations
14.
Kadekaro, Massako, et al.. (1997). Role of NO on vasopressin and oxytocin release and blood pressure responses during osmotic stimulation in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 273(3). R1024–R1030. 53 indexed citations
15.
Summy‐Long, Joan Y., Inga D. Neumann, Mary Lee Terrell, et al.. (1994). Crosstalk in the magnocellular system during osmotic stimulation of one supraoptic nucleus. Brain Research Bulletin. 33(6). 645–654. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026